Hans-Peter Hasler
Chairman en SHIELD THERAPEUTICS PLC .
Fortuna: 2 M $ al 31/03/2024
Perfil
Hans-Peter Hasler is the founder of Vicarius Pharma AG, which was founded in 2016.
He is currently the Chairman of HBM Healthcare Investments AG since 2009, the Non-Executive Chairman of Shield Therapeutics Plc since 2018, the Chairman of Medical Imaging Analysis Center since 2012, an Independent Director of Minerva Neurosciences, Inc. since 2017, an Independent Director of Gain Therapeutics, Inc. since 2021, and a Principal at Hph Management GmbH.
Mr. Hasler's former positions include Vice Chairman of Santhera Pharmaceuticals Holding AG from 2006 to 2011, Director of Acino International AG from 2008 to 2013, Independent Non-Executive Director of Dr. Reddy's Laboratories Ltd.
from 2016 to 2018, Managing Director of Wyeth Pharma GmbH, Director of Ferring Holding SA, Director of Ferring International Center SA, Independent Director of Celltrion, Inc., Managing Director of Wyeth Pharmaceuticals AG from 1993 to 1998, Director of Canyon Pharmaceuticals AG, Director of Aop Orphan Pharmaceuticals GmbH, Managing Director of Wyeth-lederle Pharma GmbH, Director of Dr. Reddy's Laboratories SA, Independent Non-Executive Director of Patheon NV from 2016 to 2017, Director of Rigi Healthcare AG, Chief Marketing Officer of Wyeth LLC, Executive Vice President-International of Biogen MA, Inc., Chief Operating Officer of Elan Corp.
Plc from 2012 to 2014, COO, EVP, Head-Global Neurology & International of Biogen, Inc. from 2001 to 2009, and Chief Marketing Officer & Senior Vice President of Wyeth Pharmaceuticals LLC from 1998 to 2001.
Mr. Hasler obtained an undergraduate degree from Schweizerisches Institut für Betriebsökonomie AG.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
31/03/2023 | 8 641 ( 0.12% ) | 2 M $ | 31/03/2024 | |
SHIELD THERAPEUTICS PLC
0.70% | 21/11/2023 | 5 500 000 ( 0.70% ) | 140 690 $ | 31/03/2024 |
GAIN THERAPEUTICS, INC.
0.12% | 23/06/2023 | 19 558 ( 0.12% ) | 73 734 $ | 31/03/2024 |
27/09/2023 | 1 250 ( 0.02% ) | 3 225 $ | 31/03/2024 |
Cargos activos de Hans-Peter Hasler
Empresas | Cargo | Inicio |
---|---|---|
HBM HEALTHCARE INVESTMENTS AG | Chairman | 01/06/2009 |
MINERVA NEUROSCIENCES, INC. | Director/Board Member | 10/12/2017 |
SHIELD THERAPEUTICS PLC | Chairman | 18/06/2020 |
GAIN THERAPEUTICS, INC. | Director/Board Member | 01/01/2021 |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler. | Founder | 01/04/2016 |
Hph Management GmbH
Hph Management GmbH Miscellaneous Commercial ServicesCommercial Services Hph Management GmbH provides business consulting services. The private company is based in Küssnacht, Switzerland. | Corporate Officer/Principal | - |
Medical Imaging Analysis Center | Chairman | 01/12/2012 |
Antiguos cargos conocidos de Hans-Peter Hasler.
Empresas | Cargo | Fin |
---|---|---|
DR. REDDY'S LABORATORIES LIMITED | Director/Board Member | 14/06/2018 |
PATHEON N.V. | Director/Board Member | 29/08/2017 |
░░░░ ░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formación de Hans-Peter Hasler.
Schweizerisches Institut für Betriebsökonomie AG | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 7 |
---|---|
BIOGEN INC. | Health Technology |
DR. REDDY'S LABORATORIES LIMITED | Health Technology |
SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
CELLTRION, INC. | Health Technology |
MINERVA NEUROSCIENCES, INC. | Health Technology |
SHIELD THERAPEUTICS PLC | Health Technology |
GAIN THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 20 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Acino International AG
Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Wyeth Pharma GmbH | Health Technology |
HBM Healthcare Investments AG
HBM Healthcare Investments AG Investment ManagersFinance HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds. | Finance |
Ferring Holding SA
Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Wyeth Pharmaceuticals AG | |
Canyon Pharmaceuticals AG | |
Aop Orphan Pharmaceuticals GmbH
Aop Orphan Pharmaceuticals GmbH BiotechnologyHealth Technology Aop Orphan Pharmaceuticals GmbH researches, develops, produces, and distributes drugs. It provides individual treatments for HematoOncology; Cardiology and Pulmonology; and Neurology and Metabolic Disorders. The company was founded by Rudolf S. Widmann in 1996 and is headquartered in Vienna, Austria. | Health Technology |
Wyeth-lederle Pharma GmbH | |
Dr. Reddy's Laboratories SA
Dr. Reddy's Laboratories SA Pharmaceuticals: MajorHealth Technology Part of Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories SA is a Swiss company that develops, manufactures and sells pharmaceutical products. The private company is based in Basel, Switzerland. | Health Technology |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Patheon NV engages in the provision of pharmaceutical development and manufacturing services. It focuses on drug development, clinical trial logistics, and commercial manufacturing. The company was founded on December 24, 2013 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Medical Imaging Analysis Center | |
Hph Management GmbH
Hph Management GmbH Miscellaneous Commercial ServicesCommercial Services Hph Management GmbH provides business consulting services. The private company is based in Küssnacht, Switzerland. | Commercial Services |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler. | Commercial Services |
Rigi Healthcare AG |
- Bolsa de valores
- Insiders
- Hans-Peter Hasler